Physician profile
Karen Evans
NPI 1023104403
$2,593.80
in general payments reported to CMS, 2019-2025
10 companies · $758 in 2025
The $758 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.61 · 2020: $22.71 · 2021: $61.90 · 2022: $36.51 · 2023: $712 · 2024: $975 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803 · Long Term Medical Supply Or Device Loan: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.65 |
| Long Term Medical Supply Or Device Loan | $641.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,528.74 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baxter Healthcare | $315.58 | 2023 | Artiss |
| Stryker Corporation | $315.26 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Smith+Nephew, INC. | $101.78 | 2020-2022 | |
| Mentor Worldwide LLC | $100.90 | 2023 | Mentor Cpx 2 Breast Tissue Expander |
| Access Pro Medical, LLC | $100.10 | 2025 | Matriderm |
| Urgo Medical North America, LLC | $72.37 | 2025 | Urgok2 |
| Acera Surgical, INC. | $29.57 | 2024 | Restrata Wound Matrix |
| Ets Wound Care LLC | $15.25 | 2025 | Mirragen Advanced Wound Matrix |
| Convatec INC. | $14.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.